Cargando…
Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687327/ https://www.ncbi.nlm.nih.gov/pubmed/23801809 http://dx.doi.org/10.2337/dc13-0295 |
| _version_ | 1782273907298926592 |
|---|---|
| author | Bergenstal, Richard M. Rosenstock, Julio Arakaki, Richard F. Prince, Melvin J. Qu, Yongming Sinha, Vikram P. Howey, Daniel C. Jacober, Scott J. |
| author_facet | Bergenstal, Richard M. Rosenstock, Julio Arakaki, Richard F. Prince, Melvin J. Qu, Yongming Sinha, Vikram P. Howey, Daniel C. Jacober, Scott J. |
| author_sort | Bergenstal, Richard M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3687327 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36873272014-07-01 Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 Bergenstal, Richard M. Rosenstock, Julio Arakaki, Richard F. Prince, Melvin J. Qu, Yongming Sinha, Vikram P. Howey, Daniel C. Jacober, Scott J. Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687327/ /pubmed/23801809 http://dx.doi.org/10.2337/dc13-0295 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Bergenstal, Richard M. Rosenstock, Julio Arakaki, Richard F. Prince, Melvin J. Qu, Yongming Sinha, Vikram P. Howey, Daniel C. Jacober, Scott J. Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title | Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_full | Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_fullStr | Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_full_unstemmed | Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_short | Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_sort | response to comment on: bergenstal et al. a randomized, controlled study of once-daily ly2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin–treated patients with type 2 diabetes. diabetes care 2012;35:2140–2147 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687327/ https://www.ncbi.nlm.nih.gov/pubmed/23801809 http://dx.doi.org/10.2337/dc13-0295 |
| work_keys_str_mv | AT bergenstalrichardm responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT rosenstockjulio responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT arakakirichardf responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT princemelvinj responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT quyongming responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT sinhavikramp responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT howeydanielc responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 AT jacoberscottj responsetocommentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 |